Evidence Synthesis
GENPHARMA's 8.12% is accelerating, up from 2.38%.
The company's .38% is also accelerating, up from .15%. On the other hand, GENPHARMA's .03 INR is decelerating, down from .07 INR.
Loading stock analysis…
Loading stock analysis…
Evidence Synthesis
Last synthesized: 22 Jul 2026, 14:16
Evidence Synthesis
GENPHARMA's 8.12% is accelerating, up from 2.38%.
The company's .38% is also accelerating, up from .15%. On the other hand, GENPHARMA's .03 INR is decelerating, down from .07 INR.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 8.12 % | 2.38 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 2.38 % | 1.15 | ▲ |
| REVENUE_GROWTH_YOY | 295.6 % | — | - |
| PRICE_CHANGE_PERCENT | -3.738 % | — | - |
| DAILY_VOLUME | 4,84,695 shares | 3,90,134 | ▲ |
| CLOSE_PRICE | 1.03 INR | 1.07 | ▼ |